HOME >> BIOLOGY >> NEWS
In New Alzheimer's Studies, Lab Tests Show Vitamin E And Other Antioxidants,,Preventing Brain Cell Death

BOSTON, Aug. 27--In laboratory tests, vitamin E prevented the death of brain cells exposed to a toxic protein found in the brains of patients with Alzheimer's disease, it was reported here today.

The protein, amyloid beta peptide (AB), is the major constituent of the senile plaques found in Alzheimer brains, and it generates oxygen free radicals that attack and kill brain cells, said Allan Butterfield, Ph.D., professor of chemistry and director of the Center for Membrane Sciences of the University of Kentucky. He presented his findings at a national meeting of the American Chemical Society, the world's largest scientific society.

Now, Dr. Butterfield says, he has become the first to see the actual death and survival of brain cells in tests of AB and antioxidants.

In one study, Dr. Butterfield added AB to the normal brain cells of test rodents and watched as all the cells died. He then pretreated rodent brain cells with Vitamin E before adding the AB. The Vitamin E prevented oxidation and cell death in almost every case, he said.

Another study, done in collaboration with colleague Mark Mattson, achieved even more dramatic result: Here Dr. Butterfield added AB to brain cells that had been genetically altered to produce antioxidants, in this case a protein called BCL-2. All of the genetically altered cells survived, he said. "The tests provide a model for how Alzheimer brain cells die-one I hope might someday light a path toward better therapies," he said.

In 1994, Dr. Butterfield postulated that AB generates oxygen free radicals that kill cells. His work helped to promote an explosion of research to determine whether antioxidants, such as vitamin E, could keep the cells alive.

Free radicals are molecules with one or more unpaired electrons that can unite with the molecules in healthy cells and ultimately kill them; antioxidants are molecules that can destroy these damaging free radicals. "I think it very
'"/>

Contact: Nancy Blount
n_blount@acs.org
(202) 872-4440
American Chemical Society
27-Aug-1998


Page: 1 2

Related biology news :

1. Alzheimers disease is not accelerated aging
2. Study explores gene transfer to modify underlying course of Alzheimers disease
3. TANGO: towards faster prognosis of Alzheimers and Parkinsons diseases?
4. DHA-rich diet protects brain from Alzheimers damage, UCLA study shows
5. Decreasing toxins in brains of Alzheimers patients keep cognitive deficits at bay
6. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
7. New UCF researchers, college will help fight Alzheimers disease, cancer
8. Herpes tool allows researchers to customize Alzheimers vaccine
9. Altered protein involved in a novel link to Alzheimers disease
10. Alzheimers may leave some forms of memory intact
11. Cancer drug resistance research leads to possible therapeutic target for Alzheimers disease

Post Your Comments:
(Date:5/21/2013)... in pharmacies and health stores, phosphatidylserine is a ... soy. Proven to improve cognition and slow memory ... experiencing memory impairment. Now a team headed by ... Tel Aviv University,s Department of Human Molecular ... improves the functioning of genes involved in degenerative ...
(Date:5/21/2013)... gathering of biomass experts , Where? ... When? 03-07 June 2013 , ... resource assessment, market and policy developments, manufacturing and installation, ... and benefiting from its 2013 edition from a record ... 60 countries, more than 240 plenary and oral presentations, ...
(Date:5/20/2013)... 2013) University of Minnesota Medical School researchers from ... with the University,s Brain Tumor Program, have developed a ... (MPNST) that allow them to discover new genes and ... research was published this week in the journal ... method, researchers in the lab of David Largaespada, Ph.D., ...
Breaking Biology News(10 mins):Common food supplement fights degenerative brain disorders 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4U of M researchers develop model for better testing, targeting of MPNST 2
(Date:5/21/2013)... -- Personal Genome Diagnostics Inc. (PGDx), today announced that ... in genomic analysis of defined cancer subtypes to ... Medicines.  PGDx is an innovator in conducting patient-specific ... and Blueprint Medicines is an expert in developing ... patient population. "This collaboration brings together ...
(Date:5/21/2013)... CA (PRWEB) May 21, 2013 ... at the University of California, San Diego for a ... load bearing Gravitic™ MRI (Magnetic Resonance Imaging) with that ... renowned for its continued pursuit of improved healthcare by ... Spinal MRI is an extremely valuable tool for evaluating ...
(Date:5/21/2013)... Clinovo's new “CDISC Standards: Theory and Application” ... June 11th, 2013. The TechTrainings are technical hands-on classes ... step in their professional career. The class will be ... online. , Taught by Sy Truong, President at Meta-Xceed ... Theory and Application” class will give an overview of ...
(Date:5/20/2013)... -- Today, at the American Psychiatric Association (APA) Meeting ... James McGough , M.D., M.S., principal investigator and ... Neuroscience and Human Behavior and David Geffen ... California Los Angeles (UCLA), and director of clinical teaching ... at UCLA, presented the results of a Phase I ...
Breaking Biology Technology:Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Vital Imaging Makes Greater Commitment into MRI Research 2Vital Imaging Makes Greater Commitment into MRI Research 3Clinovo Launches TechTrainings on CDISC Standards 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5
Cached News: